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ABSTRACT	  	  
Over the last decades, bone disorders have steeped up due to the aging of the population 
associated with lifestyle risk factors such as obesity and reduced physical activity. 
Besides, among the young, healthy population the prevalence of complex fractures has 
also increased due to factors like locomotive accidents or extreme sports. Clinical 
situations related to complex fractures, non-union fractures; osteoporosis and fragility 
fracture; osteoarthritis; rheumatoid arthritis, and so on, demand the development of 
therapeutic elements with the ability to induce tissue regeneration, or to replace 
damaged or loss bone and restore organ function. Such is the objective of biomedical 
research. Within this, tissue engineering has emerged as a promising alternative to 
current bone augmentation and bone replacement therapies, which include the use of 
autografts and allografts. The aim of bone tissue engineering is to produce ex vivo 
implantable osseous tissue that can replace missing tissue or stimulate native bone 
regeneration. These implants would consist of the right combination of cells, 
osteoinductive molecules and biocompatible materials.	  
Biomaterials are demanded in Orthopaedics for either assisting bone repair or replacing 
bone function. The former application is fulfilled by bone graft substitutes, 
characterized by their resorbability; while the latter is fulfilled by prosthetic implants 
made up of metals. In any case the ideal biomaterial for bone repair should mimic the 
bone extracellular matrix as to its physical, mechanical and chemical properties. 	  
The aim of the present work was to evaluate the biomedical potential, in the context of 
bone therapeutic repair, of different types of materials: the mesoporous silica-based 
ceramics SBA-15 and HA-SBA-15; the ICIE and ICIE-derived Nitru bioglasses; and a 
macroporous Ti6Al4V alloy sintered by electron beam melting (EBM) into 3D 
macroporous scaffolds. Resorbable materials (ceramics and bioglasses) were evaluated 
in vitro and in vivo to assess for their biocompatible and osteconductive properties. In 
vitro studies were meant to evaluate the cellular response to the materials, and included 
culture and osteoinduction of osteoblastic and bone marrow-derived mesenchymal stem 
cells (BM-MSC) on the materials. In vivo studies looked further into the 
biocompatibility and osteoconductivity of the materials and included ectopic and 
orthotopic implantation of the materials in adult rats, followed by histopathological 
analysis of the implants and their surrounding host’s tissues. Although known to be 
biocompatible, the Ti6Al4V alloy scaffolds were evaluated in vitro to test out if EBM 
sintering renders scaffolds with good superficial properties, i.e., surfaces where cells can 
attach, grow and differentiate. Osseointegration of metal prostheses requires not only 
mechanical but also tissular integration which, in turn, requires a favourable cell 
response to the prosthesis surface. In this case, osteoblastic and BM-MSC cells were 
used to evaluate osteoconductivity, and endothelial cells were used, alone and 
cocultured with osteoblasts, were used to evaluate angioconductivity.	  
	  
I. Silica-based mesoporous ceramics: SBA-15 and HA-SBA-15	  
Particulate mesoporous silica-based ceramics SBA-15 and HA-SBA-15 were 
manufactured by Dr. Díaz-Cuenca at Instituto de Ciencia de Materiales (Sevilla, Spain). 
Two kind of particulate ceramics were used on this work: SBA-15 and HA-SBA-15. 
The main difference between them is that HA-SBA-15 contains hydroxyapatite crystals 
grown onto the SBA-15 matrix in order to combine the properties of silica-based 
ceramics with those derived from calcium phosphates.	  
Osteoblastic cells and BM-MSC cells, either cell lines or cells from primary cultures, 
were used to evaluate the biocompatibility and osteoconductivity of SBA-15 and HA-
SBA-15 materials. To study the interaction of cells with the particulate materials flat, 
standard 2D cell culture and 3D micromass culture were used. Results showed that cells 
could grow in the presence of the materials, but there seemed to exist a certain cytotoxic 
effect of the particles. Culture on OptiCellTM chambers showed that at a first stage, cells 
attached to the SBA-15 and HA-SBA-15 particles forming aggregates, but afterwards all 
particles disappeared from the culture coinciding with a certain decrease in cell density. 
Actin cytoskeleton visualization by phalloidin-TRICT staining and histochemical 
staining of alkaline phosphatase revealed altered cellular morphology, thus confirming a 
certain deleterious effect of particles on the cells.	  
To further characterize the effect of particulate SBA-15 and HA-SBA-15, nuclei manual 
counting and methylene blue assay were used to measure cell population growth in the 
presence of growing concentrations of the particulate materials. No significant 
differences were found as to culture growth between controls with no particles and 
cultures containing up to 0.1 mg/ml of particles in the culture medium. A concentration-
dependent decrease in cell growth was found for particle concentrations above that, 
more remarkable for HA-SBA-15. 	  
To figure out if the cytotoxic effect was due to dissolution products from the SBA-15 
and HA-SBA-15 particles, culture media were conditioned by one week incubation with 
0.8 mg/ml of SBA-15 or HA-SBA-15, and these conditioned media were used to culture 
osteoblastic and BM-MSC cells. Results showed no effect on cell growth, suggesting 
cytotoxicity depended on the direct interaction between the cells and the SBA-15 and 
HA-SBA-15 particles. Time-lapse confocal microscopy suggested particles were being 
internalized by the cells. Culture in the presence of Celltracker GreenTM-loaded particles 
and confocal imaging of the cells in the z-axis confirmed internalization. Upregulation 
of Lamp2 gene expression in cells cultured with particulate materials suggested a 
possible relation between particle internalization and cell death.	  
In order to elucidate if cell cytotoxicity depended on particle size, cells were cultured in 
the presence of materials with particle sizes below and above 45 nm (maximum size = 
100 nm). Methylene blue assay showed no significant difference as to cell growth, and 
time-lapse microscopy showed no difference as to cell behaviour.	  
Altogether, these results suggested particulate materials SBA-15 and HA-SBA-15 might 
have a potential in intracellular delivery of drugs or genes if used at low doses, but are 
not appropriate as cell carriers. 	  
As the particulate format of SBA-15 and HA-SBA-15 showed a potential in delivering 
molecules but not cells, they were not suitable for bone tissue engineering. To overcome 
this limitation, SBA-15 was sintered into monolithic scaffolds by Dr. Díaz-Cuenca’s 
group at ICMS-CSIC (Seville-Spain). Sintered scaffolds were called “compact” and 
“porous” according to their sintering method and inner structure. The former were solid 
while the latter contained not-inteconnected micro and macroporosity. 	  
In vitro studies were carried out seeding mouse osteoblastic cells and rat BM-MSCs on 
the sintered materials to assess cell adhesion and spreading on them. Cell staining with 
CellTracker GreenTM allowed visualization and monitoring of cells grown onto the 
materials over time. Results showed that cells could attach and populate SBA-15 
sintered materials, preferring the porous and irregular inner surfaces of the scaffolds to 
their outer, smooth surfaces. SEM imaging confirmed cells had reached confluency on 
the surface of the materials, confirming in vitro biocompatibility.	  
Then the sintered monolithic SBA-15 scaffolds were tested in vivo, implanting an 
orthotopic location between the calvaria and the periosteum of adult rats. Implants were 
recovered at different time points, fixed, embedded, sectioned and stained with 
haematoxilin-eosin, picrosirius-haematoxilin and Masson-Goldner trichrome. 
Histopathological analysis revealed a heavy inflammatory response of the host tissues 
against both compact and porous SBA-15 monoliths. At early time points, 
polymorphonuclear cells and lymphocytes surrounded the implants and, in the case of 
porous SBA-15, filled the poruses of the material. Later, the lymphoid tissue was 
substituted by fibroblastic cells, and a capsule of dense fibres was visible around the 
implant, forming a fibrotic cyst. On these late sampling times, the materials had been 
partially resorbed being porous SBA-15, as expected, the more resorbed of the two.	  
In order to check the ability of sintered porous SBA-15 to deliver osteogenic molecules, 
the monolithic scaffolds were loaded with BMP2 and implanted ectopically between the 
dorsal musculature of adult rats. An already well-known bone substitute, hidroxiapatite 
(HA), was used as control material. Implants were dissected out after 7 and 21 days and 
processed for histopathological analysis as previously described. In this case, porous 
SBA-15 implants also elicited host rejection, but BMP2-loaded SBA-15 implants did 
not. The material appeared surrounded by fibroblasctic cells and no fibrotic cyst 
formation occurred. This different performance of BMP-loaded and unloaded materials 
confirmed the ability of sintered SBA-15 to deliver BMP2, although it did not perform 
as well as the HA controls, where some ossification nodules could be found when 
loaded with the same dose of BMP-2.	  
In conclusion, sintered SBA-15 material, although biocompatible in vitro, lacks the 
needed in vivo biocompatibility pursued in a bone substitute or in a tissue-engineering 
scaffold. However, it is resorbable in vivo and can be functionalized with osteinductive 
molecules as BMP-2. These characteristics encourage its modification by material 
researchers in order to make it more biocompatible.	  
	  
II. ICIE and ICIE-derived nitrided bioglass 	  
The goal of this chapter was to evaluate the biocompatibility of a nitrided ICIE-derived 
bioglass, named Nitru. ICIE, ICIE-SBN and Nitru bioglasses were provided by Dr. 
Orgaz’s group, at Instituto de Cerámica y Vidrio de Madrid (ICV-CSIC). The murine 
osteoprogenitor cell line MC3T3-E1, a well known in vitro model of osteogenic 
differentiation, was used to in vitro evaluate the biocompatibility and osteoconductivity 
of the bioglass scaffolds. MC3T3-E1 cells were seeded in the hydrophilic OH (ICIE and 
ICIE-SBN) and NH2-functionalized bioglasses (Nitru), and kept in culture for seven 
days. Nuclei were labelled with Hoechst 33352 and monitored daily in a dissecting 
microscope. Photographs were taken at different time points to assess cell presence, 
viability and distribution within the glass surfaces. Cell proliferation within the 
scaffolds was assessed by MTT assay. Scanning electron microscopy was used to 
analyse cell morphology and cell-bioglass contacts. Progression of osteogenic 
differentiation was assessed by alkaline phosphatase activity assay (pNPP substrate), 
and by alkaline phosphatase staining with Fast Red Violet LP/Naftol AS-BI phosphate. 
Cells attached to and grew on all three bioglass types, and their morphology was 
indicative of a good interaction with the bioglasses surface. MTT assay confirmed cell 
growth an all the bioglasses, being this growth significantly higher in the Nitru bioglass. 
ALP assays confirmed quantitatively and qualitatively that osseous differentiation 
occurred upon proper stimulation. Interestingly, cells seeded on ICIE bioglass needed a 
period of adaptation to the substrate prior to being able to respond to the differentiating 
stimulus. This adaptation was not needed in cells seeded in Nitru bioglass, suggesting a 
better relationship of the cells with the nitrided surface.	  
To characterize the in vivo performance of Nitru bioglasses, chips of this material were 
implanted within the dorsal muscles of adult rats and the implants were recovered after 
7 and 21 days. A set of chips was implanted as-sinthesized, and a second set was 
impregnated in BMP2 (suboptimal dose) prior to implantation. Histopathological 
analysis showed that both nude and BMP2-impregnated Nitru chips were biocompatible 
and ressorbable, as host cells were found to have entered and populated the materials. 
All the bioglasses pores were filled with cells, extracellular matrix and blood vessels. 
The tissue inside the bioglass pores changed with time to a less cellular, and more 
fibrous, likely more mature connective tissue type. Although no bone was formed in any 
of the implants (BMP2 was at suboptimal concentration), population and differentiation 
were more advanced in BMP2-impregnated Nitru chips, confirming that Nitru 
bioglasses can retain and deliver BMP2. 	  
In conclusion, the new nitrided ICIE-derived bioglass has shown to be biocompatible 
and osteoconductive both in vitro and in vivo, although not osteoinductive per se. 
Nevertheless, it can be functionalized with osteoinductive molecules like BMP2. These 
data suggest nitrided ICIE-derived bioglass may become an acceptable therapeutic 
option for bone tissue repair, either as a bone substitute or as tissue engineering scaffold, 
in combination with stem cells and osteogenic molecules. 	  
	  
III. Ti6Al4V alloy sintered by Electron Beam Melting (Ti-EBM)	  
Titanium scaffolds were designed and manufactured by Donato Monopoli’s group, at 
the Department of Mechanical Engineering of Instituto Tecnológico de Canarias (ITC). 
Our goal was to confirm the superficial properties of the EBM-sintered scaffolds were 
appropriate to favour the osseointegration of such scaffolds, i.e., cell response to EBM-
sintered titanium was favourable so that the different cell types present in bone would be 
able to adhere, spread and differentiate on the EBM-Ti surface. For this purpose, 
osteoblastic cells, BM-MSCs and endothelial cells were cultured, alone or in coculture, 
on the titanium scaffolds, and their behaviour monitored.	  
Both flat perforated discs and 3D macroporous cylinders were used. Osteoblastic and 
BM-MSC were seeded on the titanium and monitored by Hoescht 33342 nuclei staining 
and periodic observation and imaging. Cells attached to and grew on the Ti-EBM 
scaffolds, and with time they bridged the pores of the scaffold, as if trying to fill in these 
pores. Cell growth was confirmed by MTT assay, and cell phenotype was further 
observed by SEM, confirming that cells had spread all over the titanium surface, 
covering it up completely. Osseous differentiation was assessed by alkaline phosphatase 
activity, and by inmunodetection of collagen type I and bone sialoprotein.	  
In order to evaluate the potential of Ti-EBM to become vascularised, endothelial cells 
(HuVEC and HDMEC) were cultured on flat and 3D Ti-EBM scaffolds, either nude or 
fibronectin-coated. Endothelial cells attached to both coated and nude titanium 
scaffolds, and grew on it, as confirmed by Calcein AM staining and expression of the 
endothelial marker PECAM-1. To evaluate if endothelial cells adapted well to the Ti-
EBM surface, E-Selectin expression was studied. Endothelial cells were seeded onto 
nude and fibronectin-coated Ti-EBM scaffolds and E-selectin expression was detected 
by immunofluorescence. E-selectin expression was observed only in positive controls, 
which had been exposed to E. coli’s LPS, but it was not observed on the endothelial 
cells in contact with Ti-EBM scaffold. Therefore, this material does not elicit an 
inflammatory response in endothelial cells.	  
To in vitro mimic a bone environment cocultures of osteoblastic and endothelial cells 
were carried out. Ti-EBM scaffolds were seeded with human osteoblastic and 
endothelial cells and the progression of the cultures followed up by ALP fluorescent 
staining and PECAM-1 immunofluorescence to check osteoblastic and endothelial 
differentiation, respectively. Osteoblastic cells grew and spread over the titanium 
forming a cell layer to which endothelial cells attached. Endothelial cells grew over the 
osteoblastic layer for three weeks, forming a layer themselves, and afterwards 
rearranged themselves into tubes. Tube formation coincided with an upregulation of 
VEGF protein secretion, as confirmed by ELISA measures of the culture medium.	  
In summary, titanium scaffolds sintered by EBM allow adhesion, growth and 
differentiation of osteoblastic, BM-MSC and endothelial cells. These osteoconductive 
and angioconductive properties would not only favour osseointegration of prostheses 
made up of EBM-Ti, they also open up the possibility of implanting the prosthesis in 
combination with cells to promote prosthesis interaction with host bone, and to 
stimulate bone formation inside the scaffold macropores, to further accelerate and 





Conclus  ions 
1- SBA-15 and HA-SBA-15 particulate materials exert/produce/have a concentration-dependent a 
cytotoxic effec on osteoblastic cells and BM-MSC. Cytotoxicity is higher for HA-SBA-15.
2- Cytotoxic effect of SBA-15 and HA-SBA-15 does not depend of dissolution products released by 
the particles, but on the direct interaction between the cells and the material
3- Cells internalize SBA-15 and HA-SBA-15 particles. It is possible, though, that other factos add 
up to the cytotoxic effects of these particulate materials.
4- Sintered SBA-15 materials, either as compact or porous monoliths, are biocompatible in vitro 
(they can be populated by osteoblastic cells).
5- Sintered SBA-15 materials, either as compact or porous monoliths, are resorbable in vivo, being 
in porous form the faster resorbed.
6- Sintered SBA-15 materials, either as compact or porous monoliths, are not biocompatible in 
vivo, as they trigger a foreign-body rejection reaction of the host’s tissues that involves granuloma 
and fibrous-cyst formation .
7- SBA-15 sintered into porous monoliths can adsorbe and deliver active BMP2. Impregnation of 
SBA-15 with BMP2 makes it biocompatible (foreign body rejection stops to occur), but it does not 
stimulate bone formation at the implant site.
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Conclusions / Conclusiones
8- ICIE bioglasses (ICIE-16, ICIE-SBN and Nitru) are biocompatible and osteoconductive in vitro, 
being Nitru the most favorable to cell growth and differentiation.
9- Nitrided bioglass (Nitru) is biocompatible and resorbable in vivo, and it can adsorb and deliver 
biologically active BMP2.
10- Ti6Al4V ELI alloy sintered by Electron Beam Melting are osteoconductive and angioconductive 
in vitro.
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